VicTAG chemotherapy audit toolkit: Improving chemotherapy quality and safety

被引:0
|
作者
O'Connor, Shaun [1 ,2 ]
Matthews, Helen [3 ]
Hornby, Colin [1 ]
机构
[1] Commissioning & Syst Improvement, Dept Hlth, 50 Lonsdale St, Melbourne, Vic 3000, Australia
[2] St Vincents Publ Hosp, Melbourne, Vic, Australia
[3] Victorian Therapeut Advisory Grp, Melbourne, Vic, Australia
关键词
Chemotherapy; quality; auditing; safety; variation; PHYSICIAN ORDER ENTRY; ORAL CHEMOTHERAPY; ANTINEOPLASTIC DRUGS; PRESCRIBING ERRORS; MEDICATION ERRORS; IMPACT; PRESCRIPTION; CHILDREN; SYSTEM;
D O I
10.1177/10781552221148118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Off-protocol prescribing of systemic anti-cancer therapy (SACT) can lead to concerns about effectiveness of patient care. To identify variations in practice, a toolkit was developed for health services to address patient safety and the risk of sub-optimal outcomes for patients. Data sources: Following significant incidents with SACT in South Australia and New South Wales, the Department of Health and Human Services, Victoria (the department) conducted an assessment of Victorian public health services to understand current practice regarding SACT protocol governance. A literature review examining SACT auditing was also undertaken to guide improvements. A department supported Chemotherapy Audit Toolkit (CAT) was created for implementation at public hospitals in Victoria. A post-implementation survey was done on uptake and issue identification. Data summary: An initial assessment showed that 27% of Victorian public health services were undertaking retrospective review of SACT dosing, which was targeted for improvement. The literature review identified little guidance, however an audit of current sector practices found several audit methodologies. A process that involved audits by health services assessing their own practice was adopted. The toolkit was developed and piloted with health services. A post-implementation survey showed that 20% of services were using the toolkit, 35% were implementing the toolkit and 45% did not use the toolkit. Conclusions: The VicTAG CAT has been adopted by more than half of Victorian public health services and is being used to influence prescribing. Implementation of the toolkit has been affected by resource reallocation due to the COVID-19 pandemic. The CAT is available online.
引用
收藏
页码:416 / 421
页数:6
相关论文
共 50 条
  • [21] Improving Systemic Chemotherapy for Bladder Cancer
    Rose, Tracy L.
    Milowsky, Matthew I.
    CURRENT ONCOLOGY REPORTS, 2016, 18 (05)
  • [22] The safety and effect of chemotherapy with short hydration for urothelial cancer on patients' quality of life
    Azuma, Takeshi
    Matayoshi, Yukihide
    Sato, Yujiro
    Sato, Yohsuke
    Nagase, Yasushi
    Oshi, Masaya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (10) : 958 - 963
  • [23] Acute Care Use by Breast Cancer Patients on Adjuvant Chemotherapy in Alberta: Demonstrating the Importance of Measurement to Improving Quality
    Wu, Che Hsuan David
    Quan, May Lynn
    Kong, Shiying
    Xu, Yuan
    Cao, Jeffrey Q.
    Lupichuk, Sasha
    Barbera, Lisa
    CURRENT ONCOLOGY, 2021, 28 (06) : 4420 - 4431
  • [24] Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors
    Zhang, Zhengfeng
    Wang, Dazhen
    Yang, Liu
    Zhao, Lu
    Yang, Lei
    Zhang, Jianji
    Lou, Changjie
    CANCER MEDICINE, 2023, 12 (14): : 15217 - 15228
  • [25] Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study
    Pelzer, Florian
    Troeger, Wilfried
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2018, 24 (9-10) : 954 - 961
  • [26] What are the most effective strategies for improving quality and safety of health care?
    Scott, I.
    INTERNAL MEDICINE JOURNAL, 2009, 39 (06) : 389 - 400
  • [27] Safety and feasibility of chemotherapy followed by liver
    Adam, Rene
    Badrudin, David
    Chiche, Laurence
    Bucur, Petru
    Scatton, Olivier
    Granger, Victoire
    Cauchy, Francois
    Ducreux, Michel
    Cillo, Umberto
    Lesurtel, Mickael
    Mabrut, Jean -Yves
    Verslype, Chris
    Coubeau, Laurent
    Hardwigsen, Jean
    Boleslawski, Emmanuel
    Muscari, Fabrice
    Jeddou, Heithem
    Pezet, Denis
    Heyd, Bruno
    Lucidi, Valerio
    Geboes, Karen
    Lerut, Jan
    Majno, Pietro
    Grimaldi, Lamiae
    Boukhedouni, Nadjia
    Piedvache, Celine
    Gelli, Maximiliano
    Levi, Francis
    Lewin, Maite
    ECLINICALMEDICINE, 2024, 72
  • [28] Techniques and Safety Issues for Intraperitoneal Chemotherapy
    Gonzalez-Moreno, Santiago
    Ortega-Perez, Gloria
    Alonso-Casado, Oscar
    Galipienzo-Garcia, Javier
    Linero-Noguera, Manuel J.
    Salvatierra-Diaz, David
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 27 (03) : 495 - +
  • [29] Medication safety in the ambulatory chemotherapy setting
    Gandhi, TK
    Bartel, SB
    Shulman, LN
    Verrier, D
    Burdick, E
    Cleary, A
    Rothschild, JM
    Leape, LL
    Bates, DW
    CANCER, 2005, 104 (11) : 2477 - 2483
  • [30] Improving the Safety of Chemotherapy Administration: An Oncology Nurse-Led Failure Mode and Effects Analysis
    Ashley, Laura
    Dexter, Rachel
    Marshall, Fay
    McKenzie, Brenda
    Ryan, Maggie
    Armitage, Gerry
    ONCOLOGY NURSING FORUM, 2011, 38 (06) : E436 - E444